DalsnaFinance › IPOs › Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. completed its initial public offering on NASDAQ on January 8, 2021, pricing at $21.00 a share.
| Ticker | CGEM |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 8, 2021 |
| Offering price | $21.00 |
| Shares offered | 11,900,000 |
| Total raised | $250M |
Cullinan Therapeutics, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.